RxDoctor Payments Data

James Kelly

Kankakee, ILNPI 1881679553

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,835 of the $6,145 with a category attached, or 78.7%. 27 manufacturers reported payments, led by Abbott at 45.4% of the total.

$6,145in general payments, 2019–2025

Across 317 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Collegium Pharmaceutical, Inc.$455
  • Daiichi Sankyo Inc.$412
  • Arbor Pharmaceuticals, Inc.$323
  • Teva Pharmaceuticals USA, Inc.$279
  • Pfizer$251
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$4,83579%
  • Education$1,31021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →